Genentech - from United States

ID: 270188
Organization: TBI-D
Country of meeting: in the year 2012-2013

Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

Activities in the Orangization:
Donor $100,000–$249,999